Brain Tumour Primary
We asked our chief scientist, Professor Nic Jones, about why he’s so excited about our new research strategy, which we launched today.
Promising results in phase 1 trial lead immatics to continue work on vaccine (IMA950) for glioblastoma
A new cancer vaccine (IMA950) for glioblastoma has met the two primary endpoints of safety and immunogenicity in a Cancer Research UK trial.
Imagine each time you injured yourself – whether a simple cut, or a broken limb – your body’s natural healing mechanisms turned damaged muscle into bone.
Childhood cancer is no fairy story. It strikes over 30 children a week in the UK, and although survival rates have climbed dramatically over recent years – with more than...
A potential new drug can stop brain tumour cells growing while leaving healthy cells alone, according to new research published in PLOS ONE.
A small early-stage trial has produced promising results for a new cancer vaccine.
There is no link between using a mobile phone and developing tumours in the brain or central nervous system.